Serological description of neonatal umbilical cord blood from pregnant women confirmed with positive COVID-19 by RT-PCR at Rumah Sakit Umum Pusat H. Adam Malik, Medan, Indonesia
Downloads
HIGHLIGHTS
1. COVID-19 raises concern in regard with its effect on pregnancy.
2. The serological descriptions of umbilical cord of neonates born from mothers suffering from COVID-19 were identified.
3. Most of the serology was non-reactive IgG and IgM, followed was reactive IgG and the least was the reactive IgM.
ABSTRACT
Objective: To evaluate the serological description of the neonatal umbilical cord in COVID-19 mothers confirmed by RT-PCR at Rumah Sakit Umum Pusat (RSUP) H. Adam Malik Medan in January-June 2021.
Materials and Methods: This study was an observational study with a case series approach where the cases were mothers infected with SARS CoV-2 confirmed by RT-PCR. The study was conducted at Universitas Sumatera Utara (USU) Hospital Laboratory and RSUP H. Adam Malik for 6 months, from January 2021 to June 2021. The data collected were analyzed using descriptive statistics. If the data were normally distributed, they were presented as mean + SD; otherwise, they were presented as median (min-max) for each variable. The Statistical Package for Social Sciences version 22.0 (IBM SPSS Corp.; Armonk, NY, USA) was used for statistical analysis.
Results: Neonatal umbilical cord serology results (IgM and IgG) were predominantly non-reactive, where IgM was non-reactive in 43 neonates (97.7%) and IgG was non-reactive in 37 neonates (84.1%). In mothers without COVID-19 symptoms, neonate umbilical cord serology results were dominated by non-reactive IgM (88.6%) and IgG (79.5%). In mothers who recovered from COVID-19, neonate umbilical cord serology results were also dominated by non-reactive IgM (95.5%) and IgG (81.8%).
Conclusion: The neonatal umbilical cord serology results from the mother confirmed with positive COVID-19 were nonreactive IgG and IgM in the majority of 35 (79%) samples, reactive IgG in 7 (15.9%), and reactive IgM in 1 (2%) sample.
Liu H, Wang LL, Zhao SJ, et al. Why are pregnant women susceptible to COVID-19? An immuno-logical viewpoint. J Reprod Immunol. 2020;139: 103122. doi: 10.1016/j.jri.2020.103122. Epub 2020 Mar 19. PMID: 32244166; PMCID: PMC7156163.
Karimi-Zarchi M, Neamatzadeh H, Dastgheib SA, et al. Vertical transmission of Coronavirus Disease 19 (COVID-19) from infected pregnant mothers to neonates: A Review. Fetal Pediatr Pathol. 2020; 39(3):246-50. doi: 10.1080/15513815.2020.1747 120. Epub 2020 Apr 2. PMID: 32238084; PMCID: PMC7157948.
Benski C, Di Filippo D, Taraschi G, et al. Guidelines for pregnancy management during the COVID-19 pandemic: A public health conundrum. Int J Environ Res Public Health. 2020;17(21) :8277. doi: 10.3390/ijerph17218277. PMID: 3318 2412; PMCID: PMC7664946.
Yuliana, Y. Corona virus diseases (COVID-19): Sebuah tinjauan literatur. Wellness and Healthy Magazine. 2020;2(1):187-92. doi: 10.30604/well .95212020
Fenizia C, Biasin M, Cetin I, et al. Analysis of SARS-CoV-2 vertical transmission during pregnancy. Nat Commun. 2020;11(1):5128. doi: 10.1038/s41467-020-18933-4. PMID: 33046695; PMCID: PMC7552412.
Alberca RW, Pereira NZ, Oliveira LMDS, et al. Pregnancy, viral infection, and COVID-19. Front Immunol. 2020;11:1672. doi: 10.3389/fimmu.2020. 01672. PMID: 32733490; PMCID: PMC7358375.
Mahyuddin AP, Kanneganti A, Wong JJL, et al. Mechanisms and evidence of vertical transmission of infections in pregnancy including SARS-CoV-2s. Prenat Diagn. 2020;40(13):1655-70. doi: 10.1002/pd.5765. Epub 2020 Oct 4. PMID: 3252 9643; PMCID: PMC7307070.
Zeng H, Xu C, Fan J, et al. Antibodies in Infants Born to Mothers With COVID-19 Pneumonia. JAMA. 2020;323(18):1848-49. doi: 10.1001/jama. 2020.4861. PMID: 32215589; PMCID: PMC 7099444.
Kohler PF, Farr RS. Elevation of cord over maternal IgG immunoglobulin: evidence for an active placental IgG transport. Nature. 1966210 (5040):1070-1. doi: 10.1038/2101070a0. PMID: 5950290.
Kotlyar AM, Grechukhina O, Chen A, et al. Vertical transmission of coronavirus disease 2019: a systematic review and meta-analysis. Am J Obstet Gynecol. 2021;224(1):35-53.e3. doi: 10.1016/j. ajog.2020.07.049. Epub 2020 Jul 31. PMID: 3273 9398; PMCID: PMC7392880.
Mo H, Wang M, Wang M, et al. Detectable antibodies against SARS-CoV-2 in newborns from mothers infected with COVID-19 at different gestational ages. Pediatr Neonatol. 2021;62(3):321-3. doi: 10.1016/j.pedneo.2021.03.011. Epub 2021 Mar 26. PMID: 33836982; PMCID: PMC7997304.
Chen H, Guo J, Wang C, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020;395(10226):809-15. doi: 10.1016/ S0140-6736(20)30360-3. Epub 2020 Feb 12. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. PMID: 32151335; PMCID: PMC7159281.
Trevisanuto D, Cavallin F, Cavicchiolo ME, et al. Coronavirus infection in neonates: a systematic review. Arch Dis Child Fetal Neonatal Ed. 2021; 106(3):330-5. doi: 10.1136/archdischild-2020-319837. Epub 2020 Sep 17. PMID: 32943533.
Zhu H, Wang L, Fang C, et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr. 2020;9(1):51-60. doi: 10.21037/tp.2020.02.06. PMID: 32154135; PMC ID: PMC7036645.
Dong L, Tian J, He S, et al. Possible vertical transmission of SARS-CoV-2 from an infected mother to her newborn. JAMA. 2020;323(18) :1846-8. doi: 10.1001/jama.2020. 4621. PMID: 32215581; PMCID: PMC7099527.
Liu P, Zheng J, Yang P, et al. The immunologic status of newborns born to SARS-CoV-2-infected mothers in Wuhan, China. J Allergy Clin Immunol. 2020;146(1):101-9.e1. doi: 10.1016/j.jaci.2020.04. 038. Epub 2020 May 11. PMID: 32437740; PMCID: PMC7211641.
Yang H, Hu B, Zhan S, et al. Effects of Severe Acute Respiratory Syndrome Coronavirus 2 infection on pregnant women and their infants. Arch Pathol Lab Med. 2020;144(10):1217-22. doi: 10.5858/arpa.2020-0232-SA. PMID: 32422078.
Gidlöf S, Savchenko J, Brune T, et al. COVID-19 in pregnancy with comorbidities: More liberal testing strategy is needed. Acta Obstet Gynecol Scand. 2020;99(7):948-9. doi: 10.1111/aogs.13862. Epub 2020 Apr 17. PMID: 32249924.
Li Y, Zhao R, Zheng S, et al. Lack of vertical transmission of Severe Acute Respiratory Syndrome Coronavirus 2, China. Emerg Infect Dis. 2020;26(6):1335-6. doi: 10.3201/eid2606.200287. Epub 2020 Jun 17. PMID: 32134381; PMCID: PMC7258467.
Khan S, Peng L, Siddique R, et al. Impact of COVID-19 infection on pregnancy outcomes and the risk of maternal-to-neonatal intrapartum trans-mission of COVID-19 during natural birth. Infect Control Hosp Epidemiol. 2020;41(6):748-50. doi: 10.1017/ice.2020.84. PMID: 32279693; PM CID: PMC7156579.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
1. Copyright of the article is transferred to the journal, by the knowledge of the author, whilst the moral right of the publication belongs to the author.
2. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution-Non Commercial-Share alike (CC BY-NC-SA), (https://creativecommons.org/licenses/by-nc-sa/4.0/)
3. The articles published in the journal are open access and can be used for non-commercial purposes. Other than the aims mentioned above, the editorial board is not responsible for copyright violation
The manuscript authentic and copyright statement submission can be downloaded ON THIS FORM.